...
机译:基于人口BRCA测试的成本效益,随着Ashkenazi犹太人的祖先
Centre for Experimental Cancer Medicine Barts Cancer Institute Queen Mary University of London;
Centre for Experimental Cancer Medicine Barts Cancer Institute Queen Mary University of London;
Centre for Cancer Genetic Epidemiology University of Cambridge Strangeways Research Laboratory;
Medical Genetics Institute Shaare Zedek Hospital;
Barts Cancer Institute Queen Mary University of London;
Centre for Genomic Medicine Division of Evolution and Genomic science University of Manchester;
Centre for Epidemiology &
Biostatistics Melbourne School of Population &
Global Health Faculty of;
Cancer Epidemiology &
Intelligence Division Cancer Council Victoria;
Gynaecological Cancer Research Centre Department of Women’s Cancer Institute for Women’s Health;
University of New South Wales UNSW Sydney NSW;
Department of Health Services Research and Policy London School of Hygiene and Tropical Medicine;
ancestry; Ashkenazi Jewish; BRCA; cost-effectiveness; population testing;
机译:基于人口BRCA测试的成本效益,随着Ashkenazi犹太人的祖先
机译:与基于家族史的测试相比,对阿什肯纳兹犹太妇女进行BRCA突变的人群筛查的成本效益
机译:阿什妥妥·犹太女性对BRCA突变的成本效益与基于家族史的测试相比
机译:基于改进卷积神经网络的中国人口颅骨的祖先估算
机译:在主要是年轻的和现代的东正教阿什肯纳齐犹太人队列中对BRCA人群进行筛查的看法。
机译:与基于家族史的测试相比对阿什肯纳兹犹太妇女进行BRCA突变的人群筛查的成本效益
机译:基于人口的BRCa测试的成本效益与不同的德系犹太血统